首页 › 基金 › venBio Partners LLC › ATOS
venBio Partners LLC 对 ATOS 的持仓历史
ATOSSA THERAPEUTICS INC · 医疗保健
venBio Partners LLC 在 Q3 2026 的 13F 申报中披露持有 ATOS(ATOSSA THERAPEUTICS INC)4,181,366 股,市值约 US$71.7M,约占其申报组合的 14.45%,在其申报持仓中市值排名第 3 位。 venBio Partners LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
venBio Partners LLC 对 ATOS 的持仓演变
venBio Partners LLC 于 Q3 2026 首次披露 ATOS 持仓:4,181,366 股(约 US$71.7M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 4.18M | $71.67M | 新进 |
关于 ATOS 与 13F 数据
ATOS(ATOSSA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 62 只申报持有 ATOS,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$120.8M), Deep Track Capital, LP (US$55.0M), EcoR1 Capital, LLC (US$34.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ATOS 的基金
- Frazier Life Sciences Management, L.P. 7.05M 股 · $120.77M · Q3 2026
- Deep Track Capital, LP 3.21M 股 · $54.97M · Q3 2026
- EcoR1 Capital, LLC 2.02M 股 · $34.69M · Q3 2026
- Nextech Invest Ltd. 1.84M 股 · $31.45M · Q3 2026
- Cormorant Asset Management, LP 1.79M 股 · $30.66M · Q3 2026
- Redmile Group, LLC 1.16M 股 · $19.94M · Q3 2026
- Commodore Capital LP 1.16M 股 · $19.88M · Q3 2026
- Sanofi 1.08M 股 · $18.56M · Q3 2026
- Vivo Capital, LLC 300.00K 股 · $5.14M · Q3 2026
- Spruce Street Capital LP 228.29K 股 · $3.91M · Q3 2026
- Kalehua Capital Management LLC 200.00K 股 · $3.43M · Q3 2026
- Boxer Capital Management, LLC 200.00K 股 · $3.43M · Q3 2026
更多关于 venBio Partners LLC
常见问题
How long has venBio Partners LLC held ATOS?
venBio Partners LLC has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is venBio Partners LLC's current position in ATOS?
As of Q3 2026, venBio Partners LLC holds 4.18M shares of ATOS (ATOSSA THERAPEUTICS INC), valued at $71.67M, representing 14.45% of its reported portfolio and ranking #3.
Has venBio Partners LLC been buying or selling ATOS?
In the latest 13F filing (Q3 2026), venBio Partners LLC newly opened its position in ATOS.
Which other funds hold ATOS?
Other major institutional holders of ATOS include Frazier Life Sciences Management, L.P., Deep Track Capital, LP, EcoR1 Capital, LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.